Global Immuno-oncology Drugs Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-49047 | Geographical Scope: Global | Publisher: HNY Research
The global Immuno-oncology Drugs market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Amgen, Inc AstraZeneca, Plc Bristol-Myers Squibb Celgene Corporation Eli Lilly and Company Merck & Co. Hoffmann-La Roche AG Johnson & Johnson Novartis International AG AbbVie, Inc. Pfizer Inc. Sanofi S.A. EMD Serono, Inc. Gilead Sciences Inc. Prometheus Therapeutics & Diagnostics Aduro BioTech Galena Biopharma Bavarian Nordic Celldex Therapeutics ImmunoCellular Therapeutics Incyte By Types: Immune Checkpoint Inhibitors Monoclonal Antibodies Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy By Applications: Hospitals Pharmacies Online Pharmacies Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Immuno-oncology Drugs Revenue 1.5 Market Analysis by Type 1.5.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Immune Checkpoint Inhibitors 1.5.3 Monoclonal Antibodies 1.5.4 Cytokine-Based Immunotherapy 1.5.5 Cancer Vaccines 1.5.6 CAR-T Cell Therapy 1.6 Market by Application 1.6.1 Global Immuno-oncology Drugs Market Share by Application: 2022-2027 1.6.2 Hospitals 1.6.3 Pharmacies 1.6.4 Online Pharmacies 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Immuno-oncology Drugs Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Immuno-oncology Drugs Market Players Profiles 3.1 Amgen, Inc 3.1.1 Amgen, Inc Company Profile 3.1.2 Amgen, Inc Immuno-oncology Drugs Product Specification 3.1.3 Amgen, Inc Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 AstraZeneca, Plc 3.2.1 AstraZeneca, Plc Company Profile 3.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Specification 3.2.3 AstraZeneca, Plc Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Bristol-Myers Squibb 3.3.1 Bristol-Myers Squibb Company Profile 3.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Specification 3.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Celgene Corporation 3.4.1 Celgene Corporation Company Profile 3.4.2 Celgene Corporation Immuno-oncology Drugs Product Specification 3.4.3 Celgene Corporation Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Eli Lilly and Company 3.5.1 Eli Lilly and Company Company Profile 3.5.2 Eli Lilly and Company Immuno-oncology Drugs Product Specification 3.5.3 Eli Lilly and Company Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Merck & Co. 3.6.1 Merck & Co. Company Profile 3.6.2 Merck & Co. Immuno-oncology Drugs Product Specification 3.6.3 Merck & Co. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Hoffmann-La Roche AG 3.7.1 Hoffmann-La Roche AG Company Profile 3.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Specification 3.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Johnson & Johnson 3.8.1 Johnson & Johnson Company Profile 3.8.2 Johnson & Johnson Immuno-oncology Drugs Product Specification 3.8.3 Johnson & Johnson Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Novartis International AG 3.9.1 Novartis International AG Company Profile 3.9.2 Novartis International AG Immuno-oncology Drugs Product Specification 3.9.3 Novartis International AG Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 AbbVie, Inc. 3.10.1 AbbVie, Inc. Company Profile 3.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Specification 3.10.3 AbbVie, Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Pfizer Inc. 3.11.1 Pfizer Inc. Company Profile 3.11.2 Pfizer Inc. Immuno-oncology Drugs Product Specification 3.11.3 Pfizer Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Sanofi S.A. 3.12.1 Sanofi S.A. Company Profile 3.12.2 Sanofi S.A. Immuno-oncology Drugs Product Specification 3.12.3 Sanofi S.A. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 EMD Serono, Inc. 3.13.1 EMD Serono, Inc. Company Profile 3.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Specification 3.13.3 EMD Serono, Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Gilead Sciences Inc. 3.14.1 Gilead Sciences Inc. Company Profile 3.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Specification 3.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Prometheus Therapeutics & Diagnostics 3.15.1 Prometheus Therapeutics & Diagnostics Company Profile 3.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Specification 3.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Aduro BioTech 3.16.1 Aduro BioTech Company Profile 3.16.2 Aduro BioTech Immuno-oncology Drugs Product Specification 3.16.3 Aduro BioTech Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 Galena Biopharma 3.17.1 Galena Biopharma Company Profile 3.17.2 Galena Biopharma Immuno-oncology Drugs Product Specification 3.17.3 Galena Biopharma Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Bavarian Nordic 3.18.1 Bavarian Nordic Company Profile 3.18.2 Bavarian Nordic Immuno-oncology Drugs Product Specification 3.18.3 Bavarian Nordic Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 Celldex Therapeutics 3.19.1 Celldex Therapeutics Company Profile 3.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Specification 3.19.3 Celldex Therapeutics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 ImmunoCellular Therapeutics 3.20.1 ImmunoCellular Therapeutics Company Profile 3.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Specification 3.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.21 Incyte 3.21.1 Incyte Company Profile 3.21.2 Incyte Immuno-oncology Drugs Product Specification 3.21.3 Incyte Immuno-oncology Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Immuno-oncology Drugs Market Competition by Market Players 4.1 Global Immuno-oncology Drugs Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Immuno-oncology Drugs Revenue Market Share by Market Players (2016-2021) 4.3 Global Immuno-oncology Drugs Average Price by Market Players (2016-2021) 5 Global Immuno-oncology Drugs Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Immuno-oncology Drugs Market Size (2016-2021) 5.1.2 Immuno-oncology Drugs Key Players in North America (2016-2021) 5.1.3 North America Immuno-oncology Drugs Market Size by Type (2016-2021) 5.1.4 North America Immuno-oncology Drugs Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Immuno-oncology Drugs Market Size (2016-2021) 5.2.2 Immuno-oncology Drugs Key Players in East Asia (2016-2021) 5.2.3 East Asia Immuno-oncology Drugs Market Size by Type (2016-2021) 5.2.4 East Asia Immuno-oncology Drugs Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Immuno-oncology Drugs Market Size (2016-2021) 5.3.2 Immuno-oncology Drugs Key Players in Europe (2016-2021) 5.3.3 Europe Immuno-oncology Drugs Market Size by Type (2016-2021) 5.3.4 Europe Immuno-oncology Drugs Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Immuno-oncology Drugs Market Size (2016-2021) 5.4.2 Immuno-oncology Drugs Key Players in South Asia (2016-2021) 5.4.3 South Asia Immuno-oncology Drugs Market Size by Type (2016-2021) 5.4.4 South Asia Immuno-oncology Drugs Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Immuno-oncology Drugs Market Size (2016-2021) 5.5.2 Immuno-oncology Drugs Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Immuno-oncology Drugs Market Size by Type (2016-2021) 5.5.4 Southeast Asia Immuno-oncology Drugs Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Immuno-oncology Drugs Market Size (2016-2021) 5.6.2 Immuno-oncology Drugs Key Players in Middle East (2016-2021) 5.6.3 Middle East Immuno-oncology Drugs Market Size by Type (2016-2021) 5.6.4 Middle East Immuno-oncology Drugs Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Immuno-oncology Drugs Market Size (2016-2021) 5.7.2 Immuno-oncology Drugs Key Players in Africa (2016-2021) 5.7.3 Africa Immuno-oncology Drugs Market Size by Type (2016-2021) 5.7.4 Africa Immuno-oncology Drugs Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Immuno-oncology Drugs Market Size (2016-2021) 5.8.2 Immuno-oncology Drugs Key Players in Oceania (2016-2021) 5.8.3 Oceania Immuno-oncology Drugs Market Size by Type (2016-2021) 5.8.4 Oceania Immuno-oncology Drugs Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Immuno-oncology Drugs Market Size (2016-2021) 5.9.2 Immuno-oncology Drugs Key Players in South America (2016-2021) 5.9.3 South America Immuno-oncology Drugs Market Size by Type (2016-2021) 5.9.4 South America Immuno-oncology Drugs Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Immuno-oncology Drugs Market Size (2016-2021) 5.10.2 Immuno-oncology Drugs Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Immuno-oncology Drugs Market Size by Type (2016-2021) 5.10.4 Rest of the World Immuno-oncology Drugs Market Size by Application (2016-2021) 6 Global Immuno-oncology Drugs Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Immuno-oncology Drugs Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Immuno-oncology Drugs Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Immuno-oncology Drugs Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Immuno-oncology Drugs Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Immuno-oncology Drugs Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Immuno-oncology Drugs Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Immuno-oncology Drugs Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Immuno-oncology Drugs Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Immuno-oncology Drugs Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Immuno-oncology Drugs Consumption by Countries 7 Global Immuno-oncology Drugs Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Immuno-oncology Drugs (2022-2027) 7.2 Global Forecasted Revenue of Immuno-oncology Drugs (2022-2027) 7.3 Global Forecasted Price of Immuno-oncology Drugs (2022-2027) 7.4 Global Forecasted Production of Immuno-oncology Drugs by Region (2022-2027) 7.4.1 North America Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.3 Europe Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.7 Africa Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.9 South America Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Immuno-oncology Drugs Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Immuno-oncology Drugs by Application (2022-2027) 8 Global Immuno-oncology Drugs Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Immuno-oncology Drugs by Country 8.2 East Asia Market Forecasted Consumption of Immuno-oncology Drugs by Country 8.3 Europe Market Forecasted Consumption of Immuno-oncology Drugs by Countriy 8.4 South Asia Forecasted Consumption of Immuno-oncology Drugs by Country 8.5 Southeast Asia Forecasted Consumption of Immuno-oncology Drugs by Country 8.6 Middle East Forecasted Consumption of Immuno-oncology Drugs by Country 8.7 Africa Forecasted Consumption of Immuno-oncology Drugs by Country 8.8 Oceania Forecasted Consumption of Immuno-oncology Drugs by Country 8.9 South America Forecasted Consumption of Immuno-oncology Drugs by Country 8.10 Rest of the world Forecasted Consumption of Immuno-oncology Drugs by Country 9 Global Immuno-oncology Drugs Sales by Type (2016-2027) 9.1 Global Immuno-oncology Drugs Historic Market Size by Type (2016-2021) 9.2 Global Immuno-oncology Drugs Forecasted Market Size by Type (2022-2027) 10 Global Immuno-oncology Drugs Consumption by Application (2016-2027) 10.1 Global Immuno-oncology Drugs Historic Market Size by Application (2016-2021) 10.2 Global Immuno-oncology Drugs Forecasted Market Size by Application (2022-2027) 11 Global Immuno-oncology Drugs Manufacturing Cost Analysis 11.1 Immuno-oncology Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Immuno-oncology Drugs 12 Global Immuno-oncology Drugs Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Immuno-oncology Drugs Distributors List 12.3 Immuno-oncology Drugs Customers 12.4 Immuno-oncology Drugs Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000